【摘要】 目的 探討葡萄糖轉運蛋白Ⅰ型（glucose transporter 1，GLUT1）和腫瘤增殖細胞核抗原Ki-67在卵巢上皮性腫瘤組織中的表達及其臨床意義。 方法 收集2000年1月-2008年6月不同卵巢上皮性腫瘤病變患者119例的組織標本，采用免疫組織化學SP二步法檢測腫瘤組織中GLUT1和Ki-67的表達情況。 結果 卵巢交界性、惡性上皮性腫瘤灶性或廣泛高表達GLUT1和Ki-67，其表達強度有差異。卵巢良性上皮性腫瘤不表達GLUT1和Ki-67。在卵巢癌中GLUT1及Ki-67的表達強度與病理分級、臨床分期、預后有關。GLUT1表達強度與病理分型無關，Ki-67表達強度與病理分型有關。 結論 卵巢上皮性腫瘤組織中GLUT1和Ki-67的表達具有相關性，其表達強度與腫瘤的良惡性質和增殖狀態有關，二者同時檢測可以全面了解卵巢上皮性腫瘤的性質、卵巢癌惡性程度和生物學行為，對于判斷腫瘤的性質和預后有一定價值。
【Abstract】 Objective To investigate the expression and clinical significance of glucose transporter-1 (GLUT1) and tumor proliferating karyon antigen Ki-67 in epithelial ovarian tumor tissue. Methods Immunohistochemistry SP method was used to detect the expression of GLUT1 and Ki-67 protein in epithelial ovarian tumor tissues from 119 patients diagnosed in our hospital from January 2000 to June 2008. Results The expressions of GLUT1 and Ki-67 had local or abroad higher expressions in the borderline and malignant epithelial ovarian tumor, and the expressive intensity was different. In benign tumors, the expression was negative. The expressive intensity of GLUT1 and Ki-67 had correlation with the grade, stage, and prognosis in malignant tumors. The expressive intensity of GLUT1 had no correlation with the type of malignant tumors, while Ki-67 related to the pathological types. Conclusion The expressions of GLUT1 and Ki-67 have relativity. The expressive intensity of GLUT1 and Ki-67 relates to the character and proliferation of epithelial ovarian tumors. The combined detection GLUT1 and Ki-67 is helpful to know the character of epithelial ovarian tumors, the malignant degree and biologic behavior of ovarian carcinoma, which is useful in estimating the character and prognosis of epithelial ovarian tumors.
引用本文： 王安群,劉靜之,楊永紅,謝剛,謝春燕,原慶會,陳中書,余江,吳小戈,劉盛均. 葡萄糖轉運蛋白Ⅰ型與腫瘤增殖細胞核抗原在卵巢上皮性腫瘤中的表達及意義. 華西醫學, 2011, 26(1): 63-65. doi: 復制